We are live on ! Find out more
FTH

Faeth Therapeutics
FTH

42 hedge funds and large institutions have $37.1M invested in Faeth Therapeutics in 2021 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 16 increasing their positions, 9 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

133% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 6

78% more repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 9

64% more capital invested

Capital invested by funds: $22.6M → $37.1M (+$14.4M)

24% more funds holding

Funds holding: 34 → 42 (+8)

0.2% more ownership

Funds ownership: 0.38% → 0.58% (+0.2%)

Holders
42
Holders Change
+8
Holders Change %
+23.53%
% of All Funds
0.74%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
16
Reduced
9
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$5.8M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$3.27M
3
Millennium Management
Millennium Management
New York
+$2.35M
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$1.2M
5
Northern Trust
Northern Trust
Illinois
+$780K

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$1.46M
2
FG
Formula Growth
Quebec, Canada
-$976K
3
Morgan Stanley
Morgan Stanley
New York
-$950K
4
MCM
Moore Capital Management
New York
-$711K
5
ZP
Zimmer Partners
New York
-$449K
Name Holding Trade Value Shares
Change 		Change in
Stake
BlackRock
1
BlackRock
New York
$10.5M +$5.8M +31,843 +175%
Vanguard Group
2
Vanguard Group
Pennsylvania
$7.86M +$3.27M +17,950 +93%
Geode Capital Management
3
Geode Capital Management
Massachusetts
$2.88M +$1.2M +6,609 +93%
Millennium Management
4
Millennium Management
New York
$2.72M +$2.35M +12,933 New
JP Morgan Chase
5
JP Morgan Chase
New York
$1.78M -$88.7K -487 -5%
State Street
6
State Street
Massachusetts
$1.77M +$619K +3,402 +68%
Northern Trust
7
Northern Trust
Illinois
$1.69M +$780K +4,287 +114%
Citadel Advisors
8
Citadel Advisors
Florida
$1.3M -$1.46M -8,020 -57%
DFO
9
Duquesne Family Office
New York
$1.05M – – –
Truist Financial
10
Truist Financial
North Carolina
$740K +$641K +3,519 New
N
11
Nuveen
North Carolina
$548K +$399K +2,190 +349%
MCM
12
Moore Capital Management
New York
$519K -$711K -3,908 -61%
Bank of New York Mellon
13
Bank of New York Mellon
New York
$495K +$261K +1,431 +155%
Charles Schwab
14
Charles Schwab
California
$491K -$76.3K -419 -15%
AA
15
ALPS Advisors
Colorado
$394K -$25.5K -140 -7%
MCCP
16
Mission Creek Capital Partners
California
$345K +$298K +1,639 New
TCM
17
Tao Capital Management
California
$345K +$298K +1,639 New
PVI
18
Pura Vida Investments
New York
$238K – – –
RhumbLine Advisers
19
RhumbLine Advisers
Massachusetts
$174K +$151K +829 New
LB
20
Leo Brokerage
Texas
$156K +$135K +742 New
Manulife (Manufacturers Life Insurance)
21
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$142K +$123K +674 New
SG Americas Securities
22
SG Americas Securities
New York
$133K +$115K +631 New
Deutsche Bank
23
Deutsche Bank
Germany
$126K +$67K +368 +158%
AIG
24
American International Group
New York
$120K +$65.4K +359 +169%
California State Teachers Retirement System (CalSTRS)
25
California State Teachers Retirement System (CalSTRS)
California
$119K +$7.1K +39 +7%
1
2

FTH Hedge Fund Activity: Q3 2021 in Review

42 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in Faeth Therapeutics (FTH) for Q3 2021, worth a combined $37.1M — up 64% from $22.6M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new FTH positions and 6 closed out — a net gain of 8 holders — while 16 added to existing stakes and 9 trimmed.

The largest buyer was BlackRock, adding an estimated $5.8M. The largest seller was Citadel Advisors, cutting an estimated $1.46M.

  • 42 institutional investors held Faeth Therapeutics (FTH) as of Q3 2021, up from 34 in Q2 2021.
  • Funds reported $37.1M of Faeth Therapeutics stock for Q3 2021, up 64% quarter-over-quarter.
  • 14 funds opened new Faeth Therapeutics positions in Q3 2021 and 6 closed out, a net change of +8 holders.
  • The largest Faeth Therapeutics buyer in Q3 2021 was BlackRock, an estimated $5.8M added.
  • The largest Faeth Therapeutics seller in Q3 2021 was Citadel Advisors, an estimated $1.46M sold.

Based on aggregated 13F filings for Q3 2021.